FDA researchers indicate that individuals given Andexxa during a clinical trial were also more than twice as likely to die than those treated by other means.
Inari Medical issued an Urgent Medical Device Labeling Correction last month, which the FDA has declared a Class I medical device recall.
Recent research has highlighted a number of previously unknown health risks linked to the use of sugar substitutes and artificial sweeteners.
Researchers warn side effects of xylitol may increase blood platelet activity, leading to blood flow concerns.
Findings come amid continuing concerns about the overuse of antipsychotics for dementia patients in long-term care facilities, which is considered a form of "chemical restraint" or nursing home abuse.
Researchers found a significantly increased risk of heart problems linked to ADHD drugs, but say the risks are not high enough to recommend avoiding use of the medications.
The medical malpractice lawsuit claims an Army hospital made several errors during gastric bypass surgery, resulting in paralysis and eventual death.
1-in-25 pregnant women worldwide are impacted by preeclampsia, which is the leading cause of pregnancy-related deaths.
The FDA warns that the recalled syringes could cause infections, blood loss, increased blood clot risks, embolism and death.
A quarter of U.S. women regularly use NSAIDs like Motrin and Advil, which may increase their risk of blood clots by a factor of 11 when combined with high risk birth control, researchers warn.
